Generic Name and Formulations:
Mesalamine 4g/60mL; enema; contains sulfites.
Mylan Specialty L.P.
Indications for ROWASA:
Mild-to-moderate distal ulcerative colitis, proctosigmoiditis, proctitis.
4g (60mL) daily at bedtime for 3–6 weeks. Retain enema for 8 hours.
Sulfasalazine allergy. Renal dysfunction; monitor urinalysis, BUN, creatinine. Asthma. Pregnancy. Nursing mothers.
Abdominal pain/cramps/discomfort, headache, flatulence, nausea, diarrhea, flu, malaise, fever, sore throat, dizziness, bloating, joint, back, or rectal pain, hemorrhoids, itching, constipation, hair loss, pancolitis, pericarditis, rash; acute intolerance syndrome (discontinue if occurs).
Enema—7, 14, 28
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses